Home › Hereditary Angioedemas › Missouri › St. Louis
Hereditary Angioedemas clinical trials in St. Louis, MO
4 studies for Hereditary Angioedemas are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
RecruitingPhase 3
- Study Site, St Louis
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
RecruitingPhase 3
- ADARx Clinical Site, St Louis
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
RecruitingPhase 3
- ADARx Clinical Site, St Louis
Donidalorsen Treatment in Children With Hereditary Angioedema
RecruitingPhase 3
- Ionis Investigative Site, St Louis
Hereditary Angioedemas trials in other cities
- Harrisburg, PA4 studies
- Washington, DC4 studies
- San Diego, CA3 studies
- Cincinnati, OH3 studies
- Concord, CA3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer71 studies
- Breast Cancer64 studies
- Metastatic Cancer53 studies
- Colorectal Cancer49 studies
- Prostate Cancer47 studies
- Cancer (all types)47 studies
- Lung Cancer39 studies
- Ovarian Cancer37 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.